Could the long-term persistence of low serum calcium levels and high serum parathyroid hormone levels during bisphosphonate treatment predispose metastatic breast cancer patients to undergo osteonecrosis of the jaw?
Could the long-term persistence of low serum calcium levels and high serum parathyroid hormone levels during bisphosphonate treatment predispose metastatic breast cancer patients to undergo osteonecrosis of the jaw?[5] / Ardine, M.; Generali, Daniele; Donadio, M.; Bonardi, MARIA SANTINA; Scoletta, M.; Vandone, A. M.; Mozzati, M.; Bertetto, O.; Bottini, A.; Dogliotti, L.; Berruti, Alfredo. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 17:8(2006), pp. 1336-1337. [10.1093/annonc/mdl045]
Could the long-term persistence of low serum calcium levels and high serum parathyroid hormone levels during bisphosphonate treatment predispose metastatic breast cancer patients to undergo osteonecrosis of the jaw?[5]
GENERALI, DANIELE;BONARDI, MARIA SANTINA;
2006-01-01
Abstract
Could the long-term persistence of low serum calcium levels and high serum parathyroid hormone levels during bisphosphonate treatment predispose metastatic breast cancer patients to undergo osteonecrosis of the jaw?Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
